As of Aug 24
| +0.03 / +3.19%|
The 1 analysts offering 12-month price forecasts for Neptune Technologies & Bioressources Inc have a median target of 1.91, with a high estimate of 1.91 and a low estimate of 1.91. The median estimate represents a +97.34% increase from the last price of 0.97.
The current consensus among 1 polled investment analysts is to Buy stock in Neptune Technologies & Bioressources Inc. This rating has held steady since August, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.